Homeostatic synaptic plasticity (HSP) helps to stabilize the neuronal network activity, which is essential for optimal information coding. Synaptic scaling is a form of homeostatic plasticity that stabilizes neuronal firing in response to activity blockade. Lead (Pb) is a ubiquitous environmental neuro-toxicant and can impair the input-specific Hebbian type synaptic plasticity, but whether Pb exerts effects in HSP remains unknown. We previously reported that blocking L-type calcium channel induces synaptic scaling, which stimulates the synthesis of all-trans retinoic acid (RA) and the expression of GluA2-lacking a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor. Given Pb is a potent blocker of calcium channel, we hypothesized Pb may participate in synaptic scaling accompanied by RA synthesis and AMPA receptor trafficking. In this study, cultured hippocampal neurons were treated with Pb (1 lM 5 min, 15 min, 4 h, 24 h, and 10 lM 24 h) alone or in combination with tetrodotoxin (TTX, 1 lM, 24 h). The results showed that Pb alone, either at 1 lM or 10 lM, cannot induce synaptic scaling. But Pb participated in synaptic scaling when concurrent with TTX (10 lM Pb þ 1 lM TTX, 24 h). Further results showed that surface heteromeric GluA1 and GluA2 AMPA receptors were increased in TTXþ Pbinduced synaptic scaling. In addition, RA was proved not to participate in TTXþ Pb-mediated synaptic scaling. Taken together, our work supported that TTXþ Pb could induce synaptic scaling and enhance synaptic accumulation of AMPAR GluA1 and GluA2 during synaptic up scaling. Our study would help for elucidation of the Pb-induced neuronal network instability mechanism.
Normal brain function requires that neurons maintain a constant overall activity level and a balance between the relative strength of individual synapses. The processes which maintain network activity within this dynamic range are collectively called homeostatic synaptic plasticity (HSP) (Turrigiano and Nelson, 2004) . Synaptic scaling is a form of HSP in which synaptic strength is regulated in a multiplicative manner, primarily through changes in the abundance of postsynaptic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors (Thiagarajan et al., 2005; Turrigiano et al., 1998) .
Lead (Pb) is a neurotoxic heavy metal, which can impair the cognition abilities and social behaviors in children (Lanphear et al., 2005; Neal et al., 2011) . Pb is also a potent high-risk factor for attention deficit hyperactivity disorder in children (Wang et al., 2008) . Our recent work showed that Pb exposure during development causes damage to the spines in hippocampal pyramidal neurons (Ge et al., 2015) . Pb poisoning may interfere with neurotransmitter release from presynaptic vesicle, as well as postsynaptic N-methyl-D-aspartic acid receptor (NMDAR) and AMPAR expression with its downstream signaling (Lau et al., 2002; Zhang et al., 2002) . In addition to acting as a NMDAR antagonist, Pb also disrupts normal NMDAR ontogeny. It has been observed in cultured neuronal systems that Pb exposure may cause lasting changes in NMDAR subunit composition and expression (Neal et al., 2011) . Developmental Pb exposure in rats is associated with alterations in the glutamate receptor (NMDA and AMPA receptor), which caused synaptic functional and morphological changes in hippocampal CA1 pyramidal neurons, thereby leading to behavioral changes (Wang et al., 2016) . Furthermore, Pb exposure disrupts the induction and maintenance of input-specific synaptic plasticity, LTP and LTD, which is the cellular mechanisms for learning and memory (Gilbert and Lasley, 2007; Wang et al., 2006) .
One particularly well-characterized form of HSP is the increase of synaptic strength induced by chronic blockade of neuronal activity with tetrodotoxin (TTX) and the NMDA receptor antagonist D-2-amino-5-phosphonovalerate (D-APV). A series of recent studies indicate that this form of HSP is mediated by the local synthesis and synaptic insertion of homomeric GluA1 receptors, which results into an increase of synaptic glutamate receptor response as manifested in an enhanced amplitude of miniature excitatory postsynaptic currents (mEPSC) (Ju et al., 2004; Sutton et al., 2004 Sutton et al., , 2006 . Our previous work reported that different protocols could induce synaptic upscaling in cultured hippocampal neurons, blockade of the action potential with TTX with or without blockade of NMDA receptors with APV and blockade of AMPA receptor with picrotoxin, 6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX). The result showed that TTX(1 lM) 48 h, CNQX (10 lM) 24 h, TTX (1 lM)þ CNQX (10 lM) 24 h, and TTX (1 lM) þ APV (100 lM) 24 h treatment could induce synaptic scaling accompanied with the retinoic acid (RA) synthesis and AMPA receptor membrane trafficking, while TTX (1 lM) 24 h treatment could not (Wang et al., 2011) . As Pb is a potent blocker of calcium channel, we were curious to explore if Pb could interfere calcium function to induce synaptic scaling (Kim and Ziff, 2014) .
In this study, we aimed to explore the participation of Pb in HSP, as well as the signals of AMPAR and its membrane trafficking mechanisms in the HSP process in cultured hippocampal neurons. We observed that Pb treatment alone cannot induce synaptic scaling, but Pb participates in the synaptic scaling when concurrent with TTX. And further the Pb-induced neuronal network instability mechanism was also investigated.
MATERIALS AND METHODS
Drugs and chemicals. The following drugs and chemicals were purchased from Sigma-Aldrich: Lead (II) acetate trihydrate, DLDithiothreitol, 4-diethylamino-benzaldehyde (DEAB), picrotoxin, CNQX, and 1-Naphthylacetylspermine trihydrochloride (NASPM). TTX and APV were purchased from Tocris Biosciences. EZ-Link Sulfo-NHS-SS-biotin and NeutrAvidin Agarose were purchased from Pierce Protein Biology.
Cell cultures and drug treatment. SD rats were supplied by the Laboratory Animal Center, Anhui Medical University, P.R. China. Experiments were performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The study was approved by the institutional animal care and use committee at Hefei University of Technology. Rat primary hippocampal neuronal cultures were prepared as previously described in Wang et al. (2011) . Stock solutions of lead acetate (100 lM, 1 mM) were made and kept at 4 C and were diluted to working concentration (1 and 10 lM) before use. Pb was added to neuronal culture medium for different duration of time (5, 15 min, 4, or 24 h). Neurons were treated with TTX (1 lM TTX, days in vitro 13 (DIV13), 24 h), APV (100 lM APV, DIV13, 24 h), TTXþAPV (1 lM TTX þ 100 lM APV, DIV13, 24 h) and TTXþPb (1 lM TTX þ 10 lM Pb and 1 lM TTX þ 1 lM Pb, DIV13, 24 h). DEAB (10 lM, DIV13, 24 h) was used to block the synthesis of RA.
Electrophysiology. Whole-cell patch-clamp recordings were made at room temperature at DIV 14 cultured neurons (Wang et al., 2011) /Mg 2þ to stop further biotinylation of the surface protein. After 4 more washes with ice-cold PBS, cells were collected using centrifugation. Biotinylated cells were solubilized with lysis buffer (PBS with 1% Triton-X100, 1% NP-40, 10% glycerol, 25 mM MgCl 2 , and a protease inhibitor cocktail). Lysates were centrifuged to remove cell debris and nuclei at 14 000 rpm for 30 min. Precleared lysate was bound overnight at 4 C using Ultralink-immobilized streptavidin beads to precipitate biotinylated proteins. Nonbiotinylated proteins were removed by centrifugation at 1000 rpm for 3 min, and the beads were washed 3 times with lysis buffer. Biotinylated surface proteins were eluted with denaturing buffer at 75 C. Surface-expressed GluA1
and GluA2 receptors were detected by western blot analysis. Proteins were separated in 8.5% SDS-PAGE gel, transferred to PVDF membrane, blocked with 5% nonfat dry milk, followed by incubation with primary antibodies overnight at 4 C. Then after, membranes were washed for 3 times and incubated with secondary antibody. The blots were visualized using ImageQuant LAS 4000 mini system (GE Healthcare). The antibodies for b-actin (ab16039, dilution ratio 1:2000), GluA1 (MAB2263, dilution ratio 1:1000), and GluA2 (MAB397, dilution ratio 1:1000) were purchased from Abcam and Millipore, respectively. The analysis was performed using Image J software.
Immunocytochemistry. The neurons were washed 3 times with PBS followed by fixing for 5 min with 4% paraformaldehyde. Surface AMPARs were labeled with primary antibody against the N-terminal extracellular domain of rat GluA1 (Millipore, MAB2263, dilution ratio 1:500) and GluA2 (Millipore, MAB397, dilution ratio 1:500). After labeling, they were permeabilized using 0.3% TritonX-100 including 5% BSA for 10 min, followed by anti vesiclar glutamate transporter 1 (VGluT1) (Abcam, ab104898, dilution ratio 1:200) to mark excitatory synapses. Subsequently, coverslips were incubated in the mixture of 2 fluorescent conjugated Alexa Fluor-conjugated 488 (FITC) and 568 (CY3) secondary antibodies. Further, images were acquired using Zeiss LSM 710 laser-scanning confocal microscope. To ensure that loss of fluorescent signal over time didn't influence analysis, all images of an experiment were acquired as close in time as possible. Images were generated on a Zeiss LSM 710 laser-scanning confocal microscope, using sequential scanning of the sample and a 63Âoil objective. For each image, 8-10 sections were taken, and brightest point projections were made. Identical settings for laser power, photomultiplier gain, and offset were used in each experiment. For the analysis of synaptic proteins, images from the same experiment were thresholded identically by intensity to exclude the diffuse/intracellular pool. We used Puncta Analyzer program for quantification synaptic puncta. Puncta analyzer runs in the "Plugins" folder in ImageJ (Aoto et al., 2013; Tracy et al., 2011) . The experiment was repeated at least 3 times from independent cultures.
Statistical analysis. All data and figures were completed with Clampfit 10.3, Mini Analysis Program, Image J, PASW Statistics 18, OriginPro 9.0 and GraphPad Prism 6. All graphs represented MEAN 6 SEM and n represented the total number of neurons (2-4 neurons per coverslip). When significant differences were examined, p values for pairwise comparisons were calculated according to 2-tailed t tests (for unpaired data). For 3 or 4 groups, single-factor ANOVA was used for statistical analysis.
RESULTS

Combination of Pb and TTX for Inducing Synaptic Scaling
To determine whether Pb exposure altered synaptic scaling, we examined mEPSC in cultured primary hippocampal pyramidal neurons from DIV 13-14. The neurons were treated with 1 mM Pb for 5 min, 10 min, 4 h, 24 h and 10 mM Pb for 24 h, respectively. There was no significant change observed in mEPSC amplitude (Supplementary Figs. 1 and 2 ). It suggested that Pb exposure at 1 or 10 mM alone had no obvious effect in synaptic scaling. Our previous report suggested that TTX (1 lM) in combination with APV (100 lM) for 24 h could significantly increase the mEPSC amplitude in cultured neurons, while TTX (1 lM) or APV (100 lM) alone could not induce mEPSC amplitude increase (Wang et al., 2011) . It has been proved Pb is a potent blocker of NMDA receptor (Gavazzo et al., 2008; Neal et al., 2011) , we wondered whether Pb is involved in activity blockade-induced HSP through NMDA receptor. To address this question, we treated the cultured neurons with Pb (1 or 10 mM) concurrent with TTX (1 mM) for 24 h. We also included TTXþAPV treatment (blocking action potentials (APs) and NMDA receptors) for 24 h as a positive control because of its well-characterized effects in inducing synaptic scaling . Representative traces of mEPSC in different treatments were shown in Figure 1A . Interestingly, TTX þ 10 mM Pb treatment prominently resulted into 23.3% increased mEPSC amplitude (Figs. 1B and 1D , Ctrl 11.6 6 0.250, TTX 11.9 6 0.603, APV 11.9 6 0.348, TTXþAPV 14.2 6 0.437, TTX þ 1 mM Pb 12.4 6 0.319, TTX þ 10 mM Pb 14.3 6 0.437; p < .0001), without affecting mEPSC frequency (Figs. 1C  and 1E ). To summarize, these results strongly suggested that Pb at higher dosage (10 mM) was critically involved in HSP when concurrent with TTX. Thereafter TTXþPb group means 1 mM TTX þ 10 mM Pb treatment for 24 h, the same as below. Homomeric GluA1-Containing AMPA Receptors Not Involved in TTX1Pb-Mediated Synaptic Scaling From the above results, the selective increase of mEPSC amplitude not the frequency by TTXþPb treatment suggested that TTXþPb involved the postsynaptic mechanism rather than presynaptic mechanism to enhance the synaptic strength in existing synapses. According to our previous studies, treatment of TTXþAPV for 24 h can stimulate GluA1-containing AMPA receptors local dendritic synthesis and trafficking to the excitatory postsynaptic membrane (Wang et al., 2011) . As 24 h TTXþPb treatment increased the mEPSC amplitude in cultured neurons resembling 24 h TTXþAPV treatment, we were interested to know whether TTXþPb enhancing synaptic transmission involves the same mechanism ie, increasing the postsynaptic GluA1-containing AMPA receptors. By bath application of 10 lM NASPM to block the GluA2-lacking AMPA receptors (Representative traces of mEPSC were shown in Figure 2A) , there was no significant change observed in mEPSC amplitude compared with TTXþPb (Figs. 2B and 2D) or frequency (Figs. 2C and 2E ). These results suggested that homomeric GluA1-containing AMPA receptors were not involved in TTXþPb-mediated synaptic scaling.
Effect of TTX1Pb on Surface Heteromeric GluA1/GluA2 AMPA Receptors Expression
In CA1 region of the hippocampus, AMPARs are principally composed of GluA1-GluA2 heteromers, with a small contribution of GluA2-GluA3 heteromers and GluA1 homomers (Lu et al., 2009; Rozov et al., 2012; Wenthold et al., 1996) . Intrigued by the synaptic upscaling induction by TTXþPb, we further examined the surface GluA1 and GluA2 expression levels with surface protein biotinylation, using biotin to bind surface proteins and Ultralink-immobilized streptavidin beads to purify surface proteins (Shen et al., 2000) . Representative surface biotinylation bands for GluA1 and GluA2 subunit in cultured hippocampal rat neurons were shown in Figure 3A . Surprisingly, different from TTXþAPV treatment (which promotes homomeric GluA1 AMPA receptors) (Wang et al., 2011) , TTXþPb significantly increased both the GluA1 ( Figure 3B , normalized to Ctrl, TTXþPb 1.28 6 0.09; p < .05, unpaired t test) and GluA2 surface expression ( Figure 3C , normalized to Ctrl, TTXþ Pb 1.41 6 0.08; p < .001, unpaired t test).
To further examine whether the synaptic increased abundance of GluA1 and GluA2 was TTXþPb induced, we performed immunocytochemistry experiments that measured the abundance of synaptic surface-exposed GluA1 and GluA2. We used antibodies of GluA1 and GluA2 subunits to probe surface receptors in nonpermeabilized neurons, using VGluT1 immunolabeling as a general marker for excitatory synapses. Our results showed that both the GluA1 and GluA2 subunit on the membrane expression were significantly increased in neurons treated with TTXþ Pb, manifested as increased GluA1 and GluA2 puncta density ( Figure 4B , Control 100 6 19.1, TTXþPb 163 6 10.8; Figure 4E , Control 100 6 14.0, TTXþPb 187.8 6 22.6), average GluA1 and GluA2 size ( Figure 4C , Control 100 6 12.6, TTXþPb 135.9 6 13.1; Figure 4F , Control 100 6 11.6, TTXþPb 170.5 6 15.7), average GluA1 and GluA2 puncta intensity ( Figure 4D , Control 100 6 9.88, TTXþPb 121 6 9.34; Figure 4G , Control 100 6 4.04, TTXþPb 187.8 6 6.28). The TTXþPb induced enhancement in synaptic abundance of GluA1 and GluA2 corroborated our observation that TTXþPb increased mEPSC amplitude (Figs. 1B and  2B ), which suggested that TTXþPb-induced synaptic scaling.
TTX1Pb-Induced Synaptic Scaling Is RA Independent
In recent reports, RA is required for synaptic scaling, especially inactivity blockade with TTXþAPV treatment (Aoto et al., 2008) . treated with TTX þ 10 lM Pb. Images were generated on a Zeiss LSM 710 laser-scanning confocal microscope, using sequential scanning of the sample and a 63 Â oil objective. We intercepted the white boxes in the images and enlarged them for observation. Density (B), size (C), and intensity (D) of GluA1-containing synapsed in Control and TTXþPb treatment neurons. Density (E), size (F), and intensity (G) of GluA2-containing synapsed in Control and TTXþPb treatment neurons (n ¼ 11-13 from 3 independent experiments, *p < .05; **p < .01). Scale bar, 10 lm.
To explore whether TTXþPb increased RA synthesis, we treated the neurons with the RA synthesis inhibitor, DEAB which is an inhibitor of retinal dehydrogenase (RALDH). The enzyme catalyzes the next step oxidation from RALDH and converts all trans retinal into RA. Repesentative traces of mEPSC were shown in Figure 5A . TTXþAPV induced synaptic scaling has been reversed when cotreatment with DEAB, which was similar with previous studies (Figure 5B ). There showed that DEAB had no obvious effect in synaptic scaling induced by TTXþPb treatment (Figs. 5B and 5D ), nor the mEPSC frequency (Figs. 5C and 5E). These results suggested that synaptic scaling induction by TTX þ 10 mM Pb was RA independent.
DISCUSSION
Pb is well known to impair the input-specific synaptic plasticity (LTP, LTD) in hippocampus. But there are still some major knowledge gaps remaining to be clarified. The key questions present whether Pb exposure could induce synaptic scaling? If so, what postsynaptic signaling pathway mediates the synaptic scaling induced by Pb?
In this study, first, we found that Pb participated in synaptic scaling in combination with TTX treatment in cultured hippocampal neurons. Second, different forms of HSP induced by TTXþAPV and TTXþ Pb stimulated the synthesis and membrane trafficking of GluA1/GluA2 AMPA receptors. Third, RA did not participate in TTXþ Pb-induced synaptic scaling.
Unlike input-specific synaptic plasticity (ie, LTP and LTD), HSP is a negative feedback mechanism that neurons use to offset excessive excitation or inhibition by adjusting their synaptic strengths (Pozo and Goda, 2010) . Synaptic scaling, a form of HSP, is ususlly revealed by experiments examining the effects of chronic activity suppression in cultured mammalian neurons. We observed that exposure of Pb alone could not induce synaptic scaling irrespective of the treatment with 1 or 10 mM, but 10 lM Pb treatment resulted into miniature excitatory neurotransmitter release which was revealed by the increase in mEPSC frequency ( Supplementary Figs. 1 and 2) , which suggested that Pb alone exposure may aim to alter presynaptic mechanism. Interestingly, 10 mM Pb exposure induced synaptic scaling when concurrent with TTX, while TTX þ 1 mM Pb could not (Figure 1 ). TTX þ 1 mM Pb exposure may not be that strong enough to induce synaptic scaling. From the fact that Pb action partially overlaps with that of zinc (Zn 2þ ) and it is a potent antagonist of the NMDAR channel (Gavazzo et al., 2008) . Our results indicated that TTX þ 10 mM Pb, which is similar to TTXþAPV, could induce synaptic scaling in cultured hippocampal neurons. Thereafter TTXþPb group means 1 mM TTX þ 10 mM Pb treatment for 24 h. Then what postsynaptic signal participates in synaptic scaling induced by TTX and Pb? It is known that the AMPA receptor synthesis and membrane insertion is the expression mechanism for synaptic scaling. AMPARs are tetrameric cation channels that mediate fast excitatory synaptic transmission in the mammalian central nervous system. Most synapses of pyramidal neurons contain GluA1 and GluA2, however, the extent to which synaptic receptors are homomers or heteromers of these 2 subunits is not known, and the subunit synthesis can be regulated by varieties of forms of activity-dependent plasticity (Jonas et Several recent studies showed that a fast adaptive form of HSP can be induced when excitatory synaptic transmission is blocked in conjunction with TTX treatment. Importantly, this rapid form of HSP is independent of transcription, and it is mediated by the local synthesis and synaptic insertion of homomeric GluA1 receptors, allowing adjustment of synaptic strength at spatially discrete locations in a neuron (Maghsoodi et al., 2008) . In our study, we applied NASPM, the homomeric GluA2-lacking AMPA receptor blocker, to cultured neurons treated with TTX and Pb (Figure 2) . The results revealed that GluA2-lacking AMPA receptors did not participate in synaptic scaling induced by TTX and Pb. Subsequently, we examined whether heteromeric GluA1/GluA2 AMPA receptors participate in synaptic scaling induced by TTX and Pb. The TTXþPb treatment increased the surface GluA1 and GluA2 expression (Figure 3) . These results suggested that TTXþPb treatment mediated the synaptic insertion of GluA1 and GluA2 AMPA receptors to the postsynaptic membrane ( Figure 6 ).
We previously reported that multiple manipulations which block glutamatergic synaptic transmission, alone or concurrent with AP blockade, and stimulate the RA synthesis. Synaptic scaling induced by such manipulations is mediated by synaptic insertion of GluA2-lacking AMPA receptors and can be blocked by RA synthesis inhibitors (Wang et al., 2011) . Moreover, simply blocking L-type calcium channels or chelating intracellular calcium strongly activates RA synthesis. But surprisingly, we blocked RA synthesis with DEAB, an inhibitor of RA and observed that DEAB did not change the mEPSC amplitude induced by TTX and Pb treatment ( Figure 5 ). Although these data indicated that TTXþPb-induced synaptic scaling is RA-independent, the exact mechanism of this effect still needs to be further investigated.
To our knowledge, this is the first ever report which revealed that Pb exposure to hippocampal neurons can induce synaptic scaling when concurrent with TTX. We also provided evidence that heteromeric GluA1/GluA2 AMPA receptors participated in this form of synaptic scaling induced by TTX and Pb, which was observed to be RA-independent. Our study supplies unique insight into understanding the molecular basis of Pb which would help to elucidate the mechanism of Pb-induced neuronal network instability.
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